{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:28:31Z","timestamp":1793816911626,"version":"4.6.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 82471560"],"award-info":[{"award-number":["Grant No. 82471560"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-04283-0","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T16:35:08Z","timestamp":1784392508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rannasangpei and its constituent crocin-1 ameliorate valproic acid\u2013induced autism-like behaviors accompanied by reduced oxidative stress and neuroinflammation"],"prefix":"10.1038","volume":"16","author":[{"given":"Rui","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1295-148X","authenticated-orcid":false,"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingkun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinqi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7529-4408","authenticated-orcid":false,"given":"Yong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"4283_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/jama.2022.23661","volume":"329","author":"T Hirota","year":"2023","unstructured":"Hirota T, King BH. Autism spectrum disorder: A review. JAMA. 2023;329:157\u201368. https:\/\/doi.org\/10.1001\/jama.2022.23661.","journal-title":"JAMA"},{"key":"4283_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1177\/10731911231173089","volume":"31","author":"Y Yu","year":"2024","unstructured":"Yu Y, Ozonoff S, Miller M. Assessment of autism spectrum disorder. Assessment. 2024;31:24\u201341. https:\/\/doi.org\/10.1177\/10731911231173089.","journal-title":"Assessment"},{"key":"4283_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/aur.2696","volume":"15","author":"J Zeidan","year":"2022","unstructured":"Zeidan J, Fombonne E, Scorah J, Ibrahim A, Durkin MS, Saxena S, et al. Global prevalence of autism: A systematic review update. Autism Res. 2022;15:778\u201390. https:\/\/doi.org\/10.1002\/aur.2696.","journal-title":"Autism Res"},{"key":"4283_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbi.2022.12.001","volume":"108","author":"HK Hughes","year":"2023","unstructured":"Hughes HK, Moreno RJ, Ashwood P. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD). Brain Behav Immun. 2023;108:245\u201354. https:\/\/doi.org\/10.1016\/j.bbi.2022.12.001.","journal-title":"Brain Behav Immun"},{"key":"4283_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106520","volume":"197","author":"RE Frye","year":"2024","unstructured":"Frye RE, Rincon N, McCarty PJ, Brister D, Scheck AC, Rossignol DA. Biomarkers of mitochondrial dysfunction in autism spectrum disorder: A systematic review and meta-analysis. Neurobiol Dis. 2024;197:106520. https:\/\/doi.org\/10.1016\/j.nbd.2024.106520.","journal-title":"Neurobiol Dis"},{"key":"4283_CR6","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.3390\/ijms24065487","volume":"24","author":"N Usui","year":"2023","unstructured":"Usui N, Kobayashi H, Shimada S. Neuroinflammation and oxidative stress in the pathogenesis of autism spectrum disorder. Int J Mol Sci. 2023;24:5487 https:\/\/doi.org\/10.3390\/ijms24065487.","journal-title":"Int J Mol Sci"},{"key":"4283_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbi.2019.04.037","volume":"79","author":"SM Matta","year":"2019","unstructured":"Matta SM, Hill-Yardin EL, Crack PJ. The influence of neuroinflammation in Autism Spectrum Disorder. Brain Behav Immun. 2019;79:75\u201390. https:\/\/doi.org\/10.1016\/j.bbi.2019.04.037.","journal-title":"Brain Behav Immun"},{"key":"4283_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105564","volume":"162","author":"P Bonsi","year":"2022","unstructured":"Bonsi P, De Jaco A, Fasano L, Gubellini P. Postsynaptic autism spectrum disorder genes and synaptic dysfunction. Neurobiol Dis. 2022;162:105564. https:\/\/doi.org\/10.1016\/j.nbd.2021.105564.","journal-title":"Neurobiol Dis"},{"key":"4283_CR9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1001\/jamapsychiatry.2022.0407","volume":"79","author":"JA Williams","year":"2022","unstructured":"Williams JA, Burgess S, Suckling J, Lalousis PA, Batool F, Griffiths SL, et al. Inflammation and brain structure in schizophrenia and other neuropsychiatric disorders: a mendelian randomization study. JAMA Psychiatry. 2022;79:498\u2013507. https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.0407.","journal-title":"JAMA Psychiatry"},{"key":"4283_CR10","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.3390\/biomedicines11112971","volume":"11","author":"J Vilela","year":"2023","unstructured":"Vilela J, Martiniano H, Marques AR, Santos JX, Asif M, Rasga C, et al. Identification of neurotransmission and synaptic biological processes disrupted in autism spectrum disorder using interaction networks and community detection analysis. Biomedicines. 2023;11:2971 https:\/\/doi.org\/10.3390\/biomedicines11112971.","journal-title":"Biomedicines"},{"key":"4283_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12519-025-00924-4","volume":"21","author":"MK Shin","year":"2025","unstructured":"Shin MK, Son Y, Yon DK, Lee J. Potential gut-brain axis-targeted therapies for autism spectrum disorder in children: opportunities and challenges. World J Pediatr. 2025;21:447\u201367. https:\/\/doi.org\/10.1007\/s12519-025-00924-4.","journal-title":"World J Pediatr"},{"key":"4283_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-024-00593-6","volume":"15","author":"Z Guo","year":"2024","unstructured":"Guo Z, Tang X, Xiao S, Yan H, Sun S, Yang Z, et al. Systematic review and meta-analysis: multimodal functional and anatomical neural alterations in autism spectrum disorder. Mol Autism. 2024;15:16. https:\/\/doi.org\/10.1186\/s13229-024-00593-6.","journal-title":"Mol Autism"},{"key":"4283_CR13","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41593-020-0665-z","volume":"23","author":"E Kelly","year":"2020","unstructured":"Kelly E, Meng F, Fujita H, Morgado F, Kazemi Y, Rice LC, et al. Regulation of autism-relevant behaviors by cerebellar-prefrontal cortical circuits. Nat Neurosci. 2020;23:1102\u201310. https:\/\/doi.org\/10.1038\/s41593-020-0665-z.","journal-title":"Nat Neurosci"},{"key":"4283_CR14","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1038\/s41380-024-02595-5","volume":"29","author":"F Yang","year":"2024","unstructured":"Yang F, You H, Mizui T, Ishikawa Y, Takao K, Miyakawa T, et al. Inhibiting proBDNF to mature BDNF conversion leads to ASD-like phenotypes in vivo. Mol Psychiatry. 2024;29:3462\u201374. https:\/\/doi.org\/10.1038\/s41380-024-02595-5.","journal-title":"Mol Psychiatry"},{"key":"4283_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s13311-023-01360-w","volume":"20","author":"SM Zohny","year":"2023","unstructured":"Zohny SM, Habib MZ, Mohamad MI, Elayat WM, Elhossiny RM, El-Salam MFA, et al. Memantine\/Aripiprazole combination alleviates cognitive dysfunction in valproic acid rat model of autism: Hippocampal CREB\/BDNF signaling and glutamate homeostasis. Neurotherapeutics. 2023;20:464\u201383. https:\/\/doi.org\/10.1007\/s13311-023-01360-w.","journal-title":"Neurotherapeutics"},{"key":"4283_CR16","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3390\/ijms24031819","volume":"24","author":"L Wang","year":"2023","unstructured":"Wang L, Wang B, Wu C, Wang J, Sun M. Autism spectrum disorder: neurodevelopmental risk factors, biological mechanism, and precision therapy. Int J Mol Sci. 2023;24:1819 https:\/\/doi.org\/10.3390\/ijms24031819.","journal-title":"Int J Mol Sci"},{"key":"4283_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.860110","volume":"13","author":"M Doi","year":"2022","unstructured":"Doi M, Usui N, Shimada S. Prenatal environment and neurodevelopmental disorders. Front Endocrinol (Lausanne). 2022;13:860110. https:\/\/doi.org\/10.3389\/fendo.2022.860110.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4283_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-022-00488-4","volume":"13","author":"S Siafis","year":"2022","unstructured":"Siafis S, Ciray O, Wu H, Schneider-Thoma J, Bighelli I, Krause M, et al. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis. Mol Autism. 2022;13:10. https:\/\/doi.org\/10.1186\/s13229-022-00488-4.","journal-title":"Mol Autism"},{"key":"4283_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/bmjebm-2021-111804","volume":"28","author":"C Fieiras","year":"2023","unstructured":"Fieiras C, Chen MH, Escobar Liquitay CM, Meza N, Rojas V, Franco JVA, et al. Risperidone and aripiprazole for autism spectrum disorder in children: an overview of systematic reviews. BMJ Evid Based Med. 2023;28:7\u201314. https:\/\/doi.org\/10.1136\/bmjebm-2021-111804.","journal-title":"BMJ Evid Based Med"},{"key":"4283_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11655-014-1893-4","volume":"21","author":"H Luo","year":"2015","unstructured":"Luo H. Traditional Tibetan medicine in China: an overview of current status and prospects. Chin J Integr Med. 2015;21:67\u201370. https:\/\/doi.org\/10.1007\/s11655-014-1893-4.","journal-title":"Chin J Integr Med"},{"key":"4283_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104688","volume":"155","author":"K Fu","year":"2020","unstructured":"Fu K, Xu M, Zhou Y, Li X, Wang Z, Liu X, et al. The Status quo and way forwards on the development of Tibetan medicine and the pharmacological research of tibetan materia Medica. Pharmacol Res. 2020;155:104688. https:\/\/doi.org\/10.1016\/j.phrs.2020.104688.","journal-title":"Pharmacol Res"},{"key":"4283_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70476","volume":"31","author":"Y Song","year":"2025","unstructured":"Song Y, Song G, Lizhen L, Liang Y, Han M, Yang Y, et al. Qishiwei zhenzhu pills protect against cerebral ischemia via the P53\/Cytochrome C\/Apoptotic protease activating factor 1-Mediated mitochondrial apoptosis pathway. CNS Neurosci Ther. 2025;31:e70476. https:\/\/doi.org\/10.1111\/cns.70476.","journal-title":"CNS Neurosci Ther"},{"key":"4283_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115891","volume":"302","author":"Y Liang","year":"2023","unstructured":"Liang Y, Xu M, Tang C, Fu K, Li X, Song Y, et al. The study of chemical components in Qishiwei Zhenzhu pills and its anti-apoptotic mechanism in cerebral ischemic based on LC-MS and network pharmacology. J Ethnopharmacol. 2023;302:115891. https:\/\/doi.org\/10.1016\/j.jep.2022.115891.","journal-title":"J Ethnopharmacol"},{"key":"4283_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2530105","volume":"2016","author":"P Wu","year":"2016","unstructured":"Wu P, Luo Y, Zhen L, Hu X, Shang Y, Liao Y, et al. Rannasangpei is a therapeutic agent in the treatment of vascular dementia. Evid Based Complement Alternat Med. 2016;2016:2530105. https:\/\/doi.org\/10.1155\/2016\/2530105.","journal-title":"Evid Based Complement Alternat Med"},{"key":"4283_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112674","volume":"254","author":"AL Hu","year":"2020","unstructured":"Hu AL, Song S, Li Y, Xu SF, Zhang F, Li C, et al. Mercury sulfide-containing Hua-Feng-Dan and 70W (Rannasangpei) protect against LPS plus MPTP-induced neurotoxicity and disturbance of gut microbiota in mice. J Ethnopharmacol. 2020;254:112674. https:\/\/doi.org\/10.1016\/j.jep.2020.112674.","journal-title":"J Ethnopharmacol"},{"key":"4283_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2251679","volume":"2021","author":"K Fu","year":"2021","unstructured":"Fu K, Zhang D, Song Y, Xu M, Wu R, Xiong X, et al. Tibetan medicine qishiwei zhenzhu pills can reduce cerebral ischemia-reperfusion injury by regulating gut microbiota and inhibiting inflammation. Evid Based Complement Alternat Med. 2021;2021:2251679. https:\/\/doi.org\/10.1155\/2021\/2251679.","journal-title":"Evid Based Complement Alternat Med"},{"key":"4283_CR27","doi-asserted-by":"publisher","first-page":"10538","DOI":"10.1007\/s12035-024-04213-5","volume":"61","author":"Y Li","year":"2024","unstructured":"Li Y, Nie Z, Du Y, Chen L, Liu Q, Wu X, et al. \u201cRNSP (Rannasangpei)\u201d rescued MK-801-induced schizophrenia-like behaviors in mice via oxidative stress and BDNF-TrkB\/Akt pathway. Mol Neurobiol. 2024;61:10538\u201350. https:\/\/doi.org\/10.1007\/s12035-024-04213-5.","journal-title":"Mol Neurobiol"},{"key":"4283_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1143286","volume":"14","author":"Y Du","year":"2023","unstructured":"Du Y, Wang YL, Chen L, Li QE, Cheng Y. Anti-depressant-like effects of rannasangpei and its active ingredient crocin-1 on chronic unpredictable mild stress mice. Front Pharmacol. 2023;14:1143286. https:\/\/doi.org\/10.3389\/fphar.2023.1143286.","journal-title":"Front Pharmacol"},{"key":"4283_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-018-0949-0","volume":"20","author":"SW White","year":"2018","unstructured":"White SW, Simmons GL, Gotham KO, Conner CM, Smith IC, Beck KB, et al. Psychosocial treatments targeting anxiety and depression in adolescents and adults on the autism spectrum: Review of the latest research and recommended future directions. Curr Psychiatry Rep. 2018;20:82. https:\/\/doi.org\/10.1007\/s11920-018-0949-0.","journal-title":"Curr Psychiatry Rep"},{"key":"4283_CR30","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1017\/S0033291718002283","volume":"49","author":"MJ Hollocks","year":"2019","unstructured":"Hollocks MJ, Lerh JW, Magiati I, Meiser-Stedman R, Brugha TS. Anxiety and depression in adults with autism spectrum disorder: a systematic review and meta-analysis. Psychol Med. 2019;49:559\u201372. https:\/\/doi.org\/10.1017\/S0033291718002283.","journal-title":"Psychol Med"},{"key":"4283_CR31","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.drudis.2020.05.001","volume":"25","author":"S Bhatt","year":"2020","unstructured":"Bhatt S, Nagappa AN, Patil CR. Role of oxidative stress in depression. Drug Discov Today. 2020;25:1270\u20136. https:\/\/doi.org\/10.1016\/j.drudis.2020.05.001.","journal-title":"Drug Discov Today"},{"key":"4283_CR32","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/ijms24010578","volume":"24","author":"S Harsanyi","year":"2022","unstructured":"Harsanyi S, Kupcova I, Danisovic L, Klein M. Selected biomarkers of depression: What are the effects of cytokines and inflammation?. Int J Mol Sci. 2022;24:578 https:\/\/doi.org\/10.3390\/ijms24010578.","journal-title":"Int J Mol Sci"},{"key":"4283_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112545","volume":"146","author":"T Behl","year":"2022","unstructured":"Behl T, Rana T, Alotaibi GH, Shamsuzzaman M, Naqvi M, Sehgal A, et al. Polyphenols inhibiting MAPK signalling pathway mediated oxidative stress and inflammation in depression. Biomed Pharmacother. 2022;146:112545. https:\/\/doi.org\/10.1016\/j.biopha.2021.112545.","journal-title":"Biomed Pharmacother"},{"key":"4283_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","volume":"299","author":"C Nicolini","year":"2018","unstructured":"Nicolini C, Fahnestock M. The valproic acid-induced rodent model of autism. Exp Neurol. 2018;299:217\u201327. https:\/\/doi.org\/10.1016\/j.expneurol.2017.04.017.","journal-title":"Exp Neurol"},{"key":"4283_CR35","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3390\/biom12111691","volume":"12","author":"A Maisterrena","year":"2022","unstructured":"Maisterrena A, Matas E, Mirfendereski H, Balbous A, Marchand S, Jaber M. The state of the dopaminergic and glutamatergic systems in the valproic acid mouse model of autism spectrum disorder. Biomolecules. 2022;12:1691 https:\/\/doi.org\/10.3390\/biom12111691.","journal-title":"Biomolecules"},{"key":"4283_CR36","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2359501","volume":"16","author":"CM Chen","year":"2024","unstructured":"Chen CM, Wu CC, Kim Y, Hsu WY, Tsai YC, Chiu SL. Enhancing social behavior in an autism spectrum disorder mouse model: investigating the underlying mechanisms of Lactiplantibacillus plantarum intervention. Gut Microbes. 2024;16:2359501. https:\/\/doi.org\/10.1080\/19490976.2024.2359501.","journal-title":"Gut Microbes"},{"key":"4283_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410728","volume":"12","author":"D Lv","year":"2025","unstructured":"Lv D, Liu A, Yi Z, Mu M, Wu M, Li X, et al. Neuroligin 1 regulates autistic-like repetitive behavior through modulating the activity of striatal D2 receptor-expressing medium spiny neurons. Adv Sci (Weinh). 2025;12:e2410728. https:\/\/doi.org\/10.1002\/advs.202410728.","journal-title":"Adv Sci (Weinh)"},{"key":"4283_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbi.2024.03.040","volume":"119","author":"ZK Liang","year":"2024","unstructured":"Liang ZK, Xiong W, Wang C, Chen L, Zou X, Mai JW, et al. Resolving neuroinflammatory and social deficits in ASD model mice: Dexmedetomidine downregulates NF-kappaB\/IL-6 pathway via alpha2AR. Brain Behav Immun. 2024;119:84\u201395. https:\/\/doi.org\/10.1016\/j.bbi.2024.03.040.","journal-title":"Brain Behav Immun"},{"key":"4283_CR39","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/schbul\/sbad172","volume":"50","author":"XL Zhong","year":"2024","unstructured":"Zhong XL, Huang Y, Du Y, He LZ, Chen YW, Cheng Y, et al. Unlocking the therapeutic potential of exosomes derived from nasal olfactory mucosal mesenchymal stem cells: Restoring synaptic plasticity, neurogenesis, and neuroinflammation in schizophrenia. Schizophr Bull. 2024;50:600\u201314. https:\/\/doi.org\/10.1093\/schbul\/sbad172.","journal-title":"Schizophr Bull"},{"key":"4283_CR40","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1038\/s12276-023-01052-7","volume":"55","author":"S Jang","year":"2023","unstructured":"Jang S, Park I, Choi M, Kim J, Yeo S, Huh SO, et al. Impact of the circadian nuclear receptor REV-ERBalpha in dorsal raphe 5-HT neurons on social interaction behavior, especially social preference. Exp Mol Med. 2023;55:1806\u201319. https:\/\/doi.org\/10.1038\/s12276-023-01052-7.","journal-title":"Exp Mol Med"},{"key":"4283_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02606-z","volume":"13","author":"Q Fu","year":"2023","unstructured":"Fu Q, Qiu R, Chen L, Chen Y, Qi W, Cheng Y. Music prevents stress-induced depression and anxiety-like behavior in mice. Transl Psychiatry. 2023;13:317. https:\/\/doi.org\/10.1038\/s41398-023-02606-z.","journal-title":"Transl Psychiatry"},{"key":"4283_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85276-9","volume":"15","author":"Q Fu","year":"2025","unstructured":"Fu Q, Qiu R, Liang J, Wu S, Huang D, Qin Y, et al. Sugemule-7 alleviates oxidative stress, neuroinflammation, and cell death, promoting synaptic plasticity recovery in mice with postpartum depression. Sci Rep. 2025;15:1426. https:\/\/doi.org\/10.1038\/s41598-025-85276-9.","journal-title":"Sci Rep"},{"key":"4283_CR43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neubiorev.2019.04.012","volume":"110","author":"T Takumi","year":"2020","unstructured":"Takumi T, Tamada K, Hatanaka F, Nakai N, Bolton PF. Behavioral neuroscience of autism. Neurosci Biobehav Rev. 2020;110:60\u201376. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.04.012.","journal-title":"Neurosci Biobehav Rev"},{"key":"4283_CR44","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1007\/s12035-019-01742-2","volume":"57","author":"G Bjorklund","year":"2020","unstructured":"Bjorklund G, Meguid NA, El-Bana MA, Tinkov AA, Saad K, Dadar M, et al. Oxidative Stress in Autism Spectrum Disorder. Mol Neurobiol. 2020;57:2314\u201332. https:\/\/doi.org\/10.1007\/s12035-019-01742-2.","journal-title":"Mol Neurobiol"},{"key":"4283_CR45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/bs.pmbts.2020.04.018","volume":"173","author":"M Thorsen","year":"2020","unstructured":"Thorsen M. Oxidative stress, metabolic and mitochondrial abnormalities associated with autism spectrum disorder. Prog Mol Biol Transl Sci. 2020;173:331\u201354. https:\/\/doi.org\/10.1016\/bs.pmbts.2020.04.018.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"4283_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115556","volume":"166","author":"Y Shu","year":"2025","unstructured":"Shu Y, Yang J, Zhang P, Zhang X, Zhao X, Yan J, et al. Selenium improves behavioral performance in a rat model of autism spectrum disorder by mitigating oxidative stress and modulating the Sirt1\/Keap1\/Nrf2\/HO-1 signaling pathway. Int Immunopharmacol. 2025;166:115556. https:\/\/doi.org\/10.1016\/j.intimp.2025.115556.","journal-title":"Int Immunopharmacol"},{"key":"4283_CR47","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1089\/ars.2017.7099","volume":"28","author":"G Aguilera","year":"2018","unstructured":"Aguilera G, Colin-Gonzalez AL, Rangel-Lopez E, Chavarria A, Santamaria A. Redox signaling, neuroinflammation, and neurodegeneration. Antioxid Redox Signal. 2018;28:1626\u201351. https:\/\/doi.org\/10.1089\/ars.2017.7099.","journal-title":"Antioxid Redox Signal"},{"key":"4283_CR48","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1017\/S1092852923000019","volume":"28","author":"B Carpita","year":"2023","unstructured":"Carpita B, Massoni L, Battaglini S, Palego L, Cremone IM, Massimetti G, et al. IL-6, homocysteine, and autism spectrum phenotypes: an investigation among adults with autism spectrum disorder and their first-degree relatives. CNS Spectr. 2023;28:620\u20138. https:\/\/doi.org\/10.1017\/S1092852923000019.","journal-title":"CNS Spectr"},{"key":"4283_CR49","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3390\/medicina59111906","volume":"59","author":"V Yildirim","year":"2023","unstructured":"Yildirim V, Simsek S, Cetin I, Dokuyucu R. Kynurenine, kynurenic acid, quinolinic acid and interleukin-6 levels in the serum of patients with autism spectrum disorder. Medicina (Kaunas). 2023;59:1906 https:\/\/doi.org\/10.3390\/medicina59111906.","journal-title":"Medicina (Kaunas)"},{"key":"4283_CR50","doi-asserted-by":"publisher","first-page":"11710","DOI":"10.3390\/ijms241411710","volume":"24","author":"N Ferencova","year":"2023","unstructured":"Ferencova N, Visnovcova Z, Ondrejka I, Hrtanek I, Bujnakova I, Kovacova V, et al. Peripheral inflammatory markers in autism spectrum disorder and attention deficit\/hyperactivity disorder at adolescent age. Int J Mol Sci. 2023;24:11710 https:\/\/doi.org\/10.3390\/ijms241411710.","journal-title":"Int J Mol Sci"},{"key":"4283_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202405655","volume":"36","author":"S Feng","year":"2024","unstructured":"Feng S, Gong Y, Xia L, Lang Y, Shen Y, Li H, et al. Calcium hexacyanoferrate (III) nanocatalyst enables redox homeostasis for autism spectrum disorder treatment. Adv Mater. 2024;36:e2405655. https:\/\/doi.org\/10.1002\/adma.202405655.","journal-title":"Adv Mater"},{"key":"4283_CR52","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41586-019-1843-6","volume":"577","author":"MD Reed","year":"2020","unstructured":"Reed MD, Yim YS, Wimmer RD, Kim H, Ryu C, Welch GM, et al. IL-17a promotes sociability in mouse models of neurodevelopmental disorders. Nature. 2020;577:249\u201353. https:\/\/doi.org\/10.1038\/s41586-019-1843-6.","journal-title":"Nature"},{"key":"4283_CR53","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3390\/ijms25010432","volume":"25","author":"Y Willinger","year":"2023","unstructured":"Willinger Y, Friedland Cohen DR, Turgeman G. Exogenous IL-17A alleviates social behavior deficits and increases neurogenesis in a murine model of autism spectrum disorders. Int J Mol Sci. 2023;25:432 https:\/\/doi.org\/10.3390\/ijms25010432.","journal-title":"Int J Mol Sci"},{"key":"4283_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-49902-8","volume":"13","author":"UTT Than","year":"2023","unstructured":"Than UTT, Nguyen LT, Nguyen PH, Nguyen XH, Trinh DP, Hoang DH, et al. Inflammatory mediators drive neuroinflammation in autism spectrum disorder and cerebral palsy. Sci Rep. 2023;13:22587. https:\/\/doi.org\/10.1038\/s41598-023-49902-8.","journal-title":"Sci Rep"},{"key":"4283_CR55","doi-asserted-by":"publisher","first-page":"BSR20181904","DOI":"10.1042\/BSR20181904","volume":"39","author":"YH You","year":"2019","unstructured":"You YH, Qin ZQ, Zhang HL, Yuan ZH, Yu X. MicroRNA-153 promotes brain-derived neurotrophic factor and hippocampal neuron proliferation to alleviate autism symptoms through inhibition of JAK-STAT pathway by LEPR. Biosci Rep. 2019;39:BSR20181904 https:\/\/doi.org\/10.1042\/BSR20181904.","journal-title":"Biosci Rep"},{"key":"4283_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104803","volume":"141","author":"AV Fortier","year":"2022","unstructured":"Fortier AV, Meisner OC, Nair AR, Chang SWC. Prefrontal circuits guiding social preference: Implications in autism spectrum disorder. Neurosci Biobehav Rev. 2022;141:104803. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104803.","journal-title":"Neurosci Biobehav Rev"},{"key":"4283_CR57","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.neuron.2014.07.016","volume":"83","author":"SS Wang","year":"2014","unstructured":"Wang SS, Kloth AD, Badura A. The cerebellum, sensitive periods, and autism. Neuron. 2014;83:518\u201332. https:\/\/doi.org\/10.1016\/j.neuron.2014.07.016.","journal-title":"Neuron"},{"key":"4283_CR58","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00401-017-1736-4","volume":"134","author":"M Varghese","year":"2017","unstructured":"Varghese M, Keshav N, Jacot-Descombes S, Warda T, Wicinski B, Dickstein DL, et al. Autism spectrum disorder: neuropathology and animal models. Acta Neuropathol. 2017;134:537\u201366. https:\/\/doi.org\/10.1007\/s00401-017-1736-4.","journal-title":"Acta Neuropathol"},{"key":"4283_CR59","doi-asserted-by":"publisher","first-page":"7571","DOI":"10.1007\/s00210-024-03777-2","volume":"398","author":"S Hosseini","year":"2025","unstructured":"Hosseini S, Ghadimi M, Reyhani N, Khazaei S, Rahmatkhah-Yazdi M, Soleimani-Farsani R, et al. BDNF and GSK-3beta expression changes underlie the beneficial effects of crocin on behavioral alterations in a rat model of autism induced by prenatal valproic acid administration. Naunyn Schmiedebergs Arch Pharmacol. 2025;398:7571\u201382. https:\/\/doi.org\/10.1007\/s00210-024-03777-2.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4283_CR60","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s11011-023-01275-7","volume":"38","author":"SA Seyedinia","year":"2023","unstructured":"Seyedinia SA, Tarahomi P, Abbarin D, Sedaghat K, Rashidy-Pour A, Yaribeygi H, et al. Saffron and crocin ameliorate prenatal valproic acid-induced autistic-like behaviors and brain oxidative stress in the male offspring rats. Metab Brain Dis. 2023;38:2231\u201341. https:\/\/doi.org\/10.1007\/s11011-023-01275-7.","journal-title":"Metab Brain Dis"},{"key":"4283_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e36122","volume":"10","author":"C Jalili","year":"2024","unstructured":"Jalili C, Gholami M, Kakebaraei S. Protective effect of crocin-loaded nanoparticles in rats following epileptic seizures: Biochemical, behavioral and histopathological outcomes. Heliyon. 2024;10:e36122. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36122.","journal-title":"Heliyon"},{"key":"4283_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110723","volume":"131","author":"M Xu","year":"2020","unstructured":"Xu M, Wu R, Liang Y, Fu K, Zhou Y, Li X, et al. Protective effect and mechanism of Qishiwei Zhenzhu pills on cerebral ischemia-reperfusion injury via blood-brain barrier and metabonomics. Biomed Pharmacother. 2020;131:110723. https:\/\/doi.org\/10.1016\/j.biopha.2020.110723.","journal-title":"Biomed Pharmacother"},{"key":"4283_CR63","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s41593-019-0445-9","volume":"22","author":"B Guo","year":"2019","unstructured":"Guo B, Chen J, Chen Q, Ren K, Feng D, Mao H, et al. Anterior cingulate cortex dysfunction underlies social deficits in Shank3 mutant mice. Nat Neurosci. 2019;22:1223\u201334. https:\/\/doi.org\/10.1038\/s41593-019-0445-9.","journal-title":"Nat Neurosci"},{"key":"4283_CR64","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/aur.2375","volume":"13","author":"JK Siemann","year":"2020","unstructured":"Siemann JK, Veenstra-VanderWeele J, Wallace MT. Approaches to understanding multisensory dysfunction in autism spectrum disorder. Autism Res. 2020;13:1430\u201349. https:\/\/doi.org\/10.1002\/aur.2375.","journal-title":"Autism Res"},{"key":"4283_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105511","volume":"157","author":"C Lage","year":"2024","unstructured":"Lage C, Smith ES, Lawson RP. A meta-analysis of cognitive flexibility in autism spectrum disorder. Neurosci Biobehav Rev. 2024;157:105511. https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105511.","journal-title":"Neurosci Biobehav Rev"},{"key":"4283_CR66","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2016.05.033","volume":"166","author":"LL Orefice","year":"2016","unstructured":"Orefice LL, Zimmerman AL, Chirila AM, Sleboda SJ, Head JP, Ginty DD. Peripheral mechanosensory neuron dysfunction underlies tactile and behavioral deficits in mouse models of ASDs. Cell. 2016;166:299\u2013313. https:\/\/doi.org\/10.1016\/j.cell.2016.05.033.","journal-title":"Cell"},{"key":"4283_CR67","doi-asserted-by":"publisher","first-page":"e176770","DOI":"10.1172\/JCI176770","volume":"134","author":"H Sun","year":"2024","unstructured":"Sun H, Shen Y, Ni P, Liu X, Li Y, Qiu Z, et al. Autism-associated neuroligin 3 deficiency in medial septum causes social deficits and sleep loss in mice. J Clin Invest. 2024;134:e176770 https:\/\/doi.org\/10.1172\/JCI176770.","journal-title":"J Clin Invest"},{"key":"4283_CR68","doi-asserted-by":"publisher","first-page":"7550","DOI":"10.3390\/ijms23147550","volume":"23","author":"G Dougnon","year":"2022","unstructured":"Dougnon G, Matsui H. Modelling Autism Spectrum Disorder (ASD) and Attention-Deficit\/Hyperactivity Disorder (ADHD) using mice and Zebrafish. Int J Mol Sci. 2022;23:7550 https:\/\/doi.org\/10.3390\/ijms23147550.","journal-title":"Int J Mol Sci"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04283-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04283-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04283-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:37:11Z","timestamp":1791970631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04283-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4283"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04283-0","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Biological and Medical Ethics Committee, Minzu University of China.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"During the preparation of this work, the authors used ChatGPT (OpenAI, San Francisco, CA, USA) to assist in language refinement in the manuscript. After using this tool, the authors reviewed, verified, and edited all generated content to ensure accuracy and integrity and take full responsibility for the content of the final manuscript.","order":3,"name":"Ethics","label":"Declaration of generative AI use","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"557"}}